Unknown authors · 2022
Researchers tested whether static magnetic fields combined with natural compounds (caffeic and chlorogenic acid) could kill melanoma cancer cells. They found that both the magnetic field and the plant compounds triggered cell death, with caffeic acid being more effective. This suggests magnetic fields might enhance natural cancer treatments.
Unknown authors · 2022
Researchers exposed human melanoma cells to power line frequency magnetic fields (50 Hz) for 96 hours and found it significantly reduced the activity of certain viral genes (HERVs) that are linked to cancer development. The study suggests this type of EMF exposure might have therapeutic potential for treating melanoma by suppressing these harmful viral elements.
Unknown authors · 2022
Researchers exposed colorectal cancer cells to 2.4 GHz radiofrequency radiation (the same frequency as WiFi and Bluetooth) for 24 hours and found it disrupted the cancer-suppressing effects of a protective molecule called miR-34a. The radiation interfered with the cells' internal clock genes and allowed cancer cells to grow and spread more easily.
Unknown authors · 2022
Researchers analyzed tumor samples from 232 Chinese patients with clear cell renal cell carcinoma, an aggressive kidney cancer. They identified three cancer subtypes with different metabolic and immune characteristics, discovering that an enzyme called NNMT promotes tumor growth by enhancing DNA repair mechanisms. The study reveals potential new treatment targets for this deadly cancer.
Hardell & Carlberg · 2021
This 2021 analysis by Hardell and Carlberg examines historical patterns of delayed cancer prevention, focusing on radiofrequency radiation from wireless devices. The researchers found increasing brain tumor rates in Sweden, particularly among 20-39 year olds, coinciding with widespread wireless phone adoption. They argue that current safety standards ignore non-thermal biological effects and call for proper health evaluation before 5G deployment.
Unknown authors · 2021
This study examined whether adding a low-dose chemotherapy drug (capecitabine) after standard radiation treatment could prevent cancer recurrence in 406 patients with advanced nasopharyngeal cancer. After 3 years, patients receiving the additional drug had significantly better survival rates (85.3% vs 75.7%) with manageable side effects. The results suggest this approach could become a new standard treatment for this aggressive cancer.
Unknown authors · 2021
Researchers exposed gastric cancer cells and normal cells to extremely low frequency magnetic fields at different strengths for 18 hours. The magnetic fields decreased cancer cell survival while increasing normal cell survival, and changed the expression of NOTCH1, a gene involved in cancer growth. This suggests ELF magnetic fields might selectively target cancer cells while protecting healthy tissue.
Unknown authors · 2021
Researchers tested whether electromagnetic fields could help overcome chemotherapy resistance in aggressive brain cancer cells. They found that combining 50 Hz EMF exposure with the drug temozolomide killed more cancer cells and reduced their ability to spread. The electromagnetic fields appeared to make the chemotherapy more effective by changing how key cancer-related genes and proteins behaved.
Unknown authors · 2021
Researchers conducted a comprehensive molecular analysis of 140 pancreatic cancer samples using advanced protein and genetic sequencing techniques. This study mapped the complete biological changes that occur in pancreatic ductal adenocarcinoma, one of the most aggressive cancers. The findings create a detailed resource to help identify new treatment targets and improve early detection methods.
Unknown authors · 2021
This international study tracked 20,006 cancer patients across 61 countries during COVID-19 to examine how lockdown restrictions affected cancer surgery delivery. Researchers found that stricter lockdowns dramatically increased surgery cancellations - from 0.6% under light restrictions to 15% during full lockdowns. The findings reveal how healthcare system disruptions can compound health risks beyond the immediate crisis.
Unknown authors · 2021
Researchers conducted a comprehensive molecular analysis of 140 pancreatic cancers using advanced protein and genetic sequencing techniques. This study created a detailed molecular map of pancreatic ductal adenocarcinoma (PDAC), one of the most aggressive cancers. The findings provide a foundation for developing better early detection methods and new treatments for this deadly disease.
Unknown authors · 2021
This appears to be clinical practice guidelines for colon cancer treatment, not an EMF research study. The abstract discusses systemic therapy options, checkpoint inhibitors, and biomarker testing for metastatic colorectal cancer. No electromagnetic field exposure or health effects were studied in this medical oncology guideline.
Shih et al · 2020
Researchers studied 894 healthy women and 211 breast cancer patients in Taiwan to examine smartphone use habits. Women with smartphone addiction had 43% higher breast cancer risk, while using phones for more than 4.5 minutes before bedtime increased risk by 427%. Carrying phones near the chest or waist increased risk 4-5 times compared to carrying them below the waist.
Unknown authors · 2020
Researchers exposed stomach cancer cells to extremely low frequency magnetic fields and found the exposure altered expression of c-Myc (a gene linked to cancer progression) and circ-CCDC66 (a regulatory RNA molecule). The effects varied depending on field strength and whether exposure was continuous or intermittent, with some conditions reducing cancer-promoting gene activity while others increased it.
Unknown authors · 2020
Researchers tested whether magnetic fields could enhance the effectiveness of brain cancer treatment. They exposed human glioblastoma cells to 10 Hz and 50 Hz magnetic fields combined with the chemotherapy drug Temozolomide. The combination increased cancer cell death and activated tumor-suppressing proteins more than chemotherapy alone.
Unknown authors · 2020
Researchers analyzed genetic data from over 2,600 cancers across 38 tumor types to identify patterns in how cancer cells rearrange their DNA. They discovered 16 distinct signatures of structural genetic changes that occur during cancer development. This comprehensive mapping reveals the complex ways cancer cells reorganize their genetic material, providing new insights into cancer biology.
Unknown authors · 2020
Researchers synthesized new benzimidazole chemical compounds and tested their ability to kill cancer cells in laboratory studies. One compound (compound 5) showed strong anti-cancer effects, stopping cell division and triggering cancer cell death while being less toxic to healthy kidney cells. This suggests potential for developing new cancer treatments from these synthetic compounds.
Unknown authors · 2020
Researchers analyzed genetic data from over 2,600 cancers across 38 tumor types to identify 16 distinct patterns of DNA structural changes that occur during cancer development. The study revealed how chromosomes get rearranged, deleted, or duplicated in different ways depending on the cancer type. This comprehensive mapping helps scientists understand the complex genetic chaos that drives cancer progression.
Unknown authors · 2020
Researchers synthesized new benzimidazole chemical compounds and tested their ability to kill cancer cells in laboratory conditions. One compound (compound 5) showed strong cancer-fighting properties, killing cancer cells while being less toxic to healthy kidney cells. The study found this compound works by stopping cancer cell division and triggering cell death.
Unknown authors · 2019
This study developed a diagnostic tool using CT scan analysis to detect hidden cancer spread in the abdomen that traditional imaging misses. Researchers analyzed CT images from 554 advanced gastric cancer patients across 4 medical centers, creating a predictive model that achieved over 92% accuracy in identifying occult peritoneal metastasis. The tool could help doctors make better treatment decisions by catching cancer spread that would otherwise go undetected until surgery.
Ahmadi-Zeidabadi, M., Z. · 2019
This 2019 review examines tumor-treating fields (TTFields), a cancer therapy that uses low-intensity, intermediate-frequency electric fields to treat deadly brain tumors called glioblastomas. The research shows TTFields significantly extends patient survival by disrupting cancer cell division and DNA repair. Clinical trials demonstrate this electromagnetic therapy works as the fourth most effective treatment option for these aggressive brain cancers.
NTP 2018. NTP Technical Report on the Toxicology and Carcinogenesis Studies in Hsd:Sprague Dawley SD Rats exposed to Whole-body Radio Frequency Radiation at a Frequency (900 MHz) and Modulations (GSM and CDMA) used by Cell Phones. National Toxicology Program et al. · 2018
The National Toxicology Program conducted a major two-year study exposing rats to 900 MHz cell phone radiation (GSM and CDMA) to test for cancer and other health effects. This was the largest government study of its kind, designed to definitively answer whether the radiofrequency radiation from cell phones poses health risks.
Belpomme et al · 2018
This comprehensive review by international researchers examined the health effects of low-intensity electromagnetic fields from sources like cell phones and wireless devices. The authors found strong evidence linking long-term mobile phone use to increased brain cancer risk, reproductive harm, and neurological problems including a condition called electro-hypersensitivity. They concluded that current safety standards fail to protect public health, especially for children who are more vulnerable to EMF damage.
Unknown authors · 2018
This 2018 meta-analysis examined whether parents' occupational exposure to extremely low frequency magnetic fields increases their children's risk of developing nervous system tumors. The research analyzed multiple studies to determine if workplace EMF exposure in parents correlates with higher rates of childhood brain and nervous system cancers.
Unknown authors · 2018
Researchers developed a DNA methylation-based system to accurately classify brain tumors, addressing the significant diagnostic challenges in identifying the approximately 100 known central nervous system tumor types. The new method changed diagnoses in up to 12% of cases compared to standard pathological examination, demonstrating substantially improved diagnostic precision.
